MITOCHONDRIAL FISSION AND NEURODEGENERATION
线粒体裂变和神经变性
基本信息
- 批准号:8361903
- 负责人:
- 金额:$ 3.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AgreementApoptoticBacterial ToxinsBindingBuffersCalciumCell DeathCell physiologyCellsChronicComplexDefectDynaminEquilibriumEventExhibitsExocytosisFamilyFilamentFree RadicalsFundingFutureGrantGuanosine Triphosphate PhosphohydrolasesHumanImage AnalysisLinkMediatingMembraneMembrane FusionMitochondriaMitochondrial DNANADH dehydrogenase (ubiquinone)National Center for Research ResourcesNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionNeuronsOuter Mitochondrial MembraneOxidative StressParkinson DiseasePatientsPreventionPrincipal InvestigatorProductionProteinsPublicationsResearchResearch InfrastructureResourcesSNAP receptorSiteSourceStructureSynapsesTestingTransgenic MiceUnited States National Institutes of Healthalpha synucleinbrain tissuecostmitochondrial DNA mutationmitochondrial dysfunctionmitochondrial membranemutantneuron lossneurotoxicityoverexpressionpreventprotein aggregationrespiratory
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
We are using NCMIR to study Parkinson's disease (PD) and related neurodegenerative disorders. We hypothesize that alpha-synuclein (a-syn) causes neurodegeneration by inducing chronic mitochondrial fission through abnormal interaction with mitochondrial fission and fusion GTPases. Our current understanding of PD suggests that a-syn-mediated disruption of mitochondrial fusion/fission events may be a mechanism of neuronal toxicity. Nevertheless, this idea has never been tested. Mitochondrial fusion is thought to provide protection by facilitating the mixing mitochondrial contents, such as metabolites and mtDNA. Several observations of a-syn are in agreement with our hypothesis. First, brain tissue of PD patients and a-syn transgenic mice exhibit abnormal mitochondrial ultrastructure, respiratory complex I inhibition, and increased free radical production. In addition, overexpression of human a-syn in transgenic mice leads to dopaminergic synaptic loss. Furthermore, a-syn modulates membrane composition and forms pores similar to bacterial toxins. Intriguingly, Bax, a pro-cell death molecule of the Bcl-2 family that associates with the mitochondrial outer membrane, also has pore-forming activity and a structure similar to bacterial toxins. Recent publications show that Bax is a component of mitochondrial fission/fusion complexes in dying cells. Finally, a-syn cooperates in SNARE complex assembly that regulates exocytosis and membrane fusion. Mitofusins (Mfns) may mediate mitochondrial membrane fusion by a SNARE-like mechanism. Thus, it is conceivable that a-syn may interact with Mfns, similar to SNAREs. Dynamin-related GTPases regulate mitochondrial fission and fusion, important cellular processes that neurons must balance to maintain normal mitochondrial and synaptic activity. Dynamin-related protein 1 (Drp1) directs mitochondrial fission (division) and Mfn 1, 2 regulate mitochondrial fusion. Previous research has linked excessive mitochondrial fission to neurodegeneration and induction of mitochondrial fusion to the prevention of neuronal cell death. Bax co-localizes with Drp1 in fission complexes on mitochondria and regulates apoptotic mitochondrial fission. We believe that a-syn, like Bax, may interact with the Mfns or Drp1. Supporting this hypothesis is the observation that a-syn forms clusters on mitochondria that may constitute future or past fission sites. Mutant or abnormally folded a-syn may inhibit Mfn GTPase function and prevent mitochondrial fusion. Alternatively, a-syn may bind and activate Drp1, thereby promoting excessive fission. The consequences of such interactions might include the breakdown of long mitochondrial filaments into multiple, isolated fragments, chronic respiratory inhibition, increased free radical levels, impaired calcium buffering, energy decline, accumulation and manifestation of mtDNA mutations, and ultrastructural defects of mitochondria. Mitochondrial dysfunction, energy crisis, and oxidative stress would then cause loss of synapses, protein aggregation, and neuronal dysfunction and loss.
这个子项目是许多利用资源的研究子项目之一
由NIH/NCRR资助的中心拨款提供。子项目的主要支持
而子项目的主要调查员可能是由其他来源提供的,
包括其它NIH来源。 列出的子项目总成本可能
代表子项目使用的中心基础设施的估计数量,
而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。
我们正在使用NCMIR来研究帕金森病(PD)和相关的神经退行性疾病。我们假设α-突触核蛋白(α-syn)通过与线粒体分裂和融合GTP酶的异常相互作用诱导慢性线粒体分裂而引起神经变性。我们目前对PD的理解表明,α-syn介导的线粒体融合/分裂事件的破坏可能是神经元毒性的机制。然而,这一想法从未得到验证。线粒体融合被认为通过促进线粒体内容物(如代谢物和mtDNA)的混合来提供保护。对a-syn的几个观察结果与我们的假设一致。首先,PD患者和a-syn转基因小鼠的脑组织表现出异常的线粒体超微结构、呼吸复合物I抑制和增加的自由基产生。此外,人a-syn在转基因小鼠中的过表达导致多巴胺能突触损失。此外,α-syn调节膜组成并形成类似于细菌毒素的孔。有趣的是,Bax是Bcl-2家族的促细胞死亡分子,与线粒体外膜相关,也具有孔形成活性和类似于细菌毒素的结构。最近的出版物表明,Bax是垂死细胞中线粒体分裂/融合复合物的组成部分。最后,α-syn在调节胞吐和膜融合的SNARE复合物组装中协作。线粒体融合素(Mitofusins,Mfns)可通过SNARE样机制介导线粒体膜融合。因此,可以想象a-syn可以与Mfn相互作用,类似于SNARE。动力蛋白相关的GTP酶调节线粒体分裂和融合,这是神经元必须平衡以维持正常线粒体和突触活性的重要细胞过程。动力蛋白相关蛋白1(Drp 1)指导线粒体分裂(分裂),Mfn 1,2调节线粒体融合。先前的研究已经将过度的线粒体分裂与神经变性联系起来,并将诱导线粒体融合与预防神经元细胞死亡联系起来。Bax与Drp 1共定位于线粒体上的裂变复合物中并调节凋亡线粒体裂变。我们相信a-syn和Bax一样,可能与Mfns或Drp 1相互作用。支持这一假设的是观察到a-syn在线粒体上形成簇,这些簇可能构成未来或过去的裂变位点。突变或异常折叠的α-syn可抑制Mfn GT3功能并阻止线粒体融合。或者,α-syn可以结合并激活Drp 1,从而促进过度裂变。这种相互作用的后果可能包括线粒体长丝分解成多个孤立的片段,慢性呼吸抑制,自由基水平增加,钙缓冲受损,能量下降,线粒体DNA突变的积累和表现,以及线粒体的超微结构缺陷。线粒体功能障碍、能量危机和氧化应激将导致突触丢失、蛋白质聚集和神经元功能障碍和丧失。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ella R Bossy-Wetzel其他文献
Ella R Bossy-Wetzel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ella R Bossy-Wetzel', 18)}}的其他基金
Lysine Acetylation as Switch for Optic Atrophy 1 Inactivation
赖氨酸乙酰化作为视神经萎缩 1 失活的开关
- 批准号:
9887403 - 财政年份:2020
- 资助金额:
$ 3.95万 - 项目类别:
相似海外基金
Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
- 批准号:
10607815 - 财政年份:2023
- 资助金额:
$ 3.95万 - 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
- 批准号:
10723868 - 财政年份:2023
- 资助金额:
$ 3.95万 - 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
- 批准号:
10862033 - 财政年份:2023
- 资助金额:
$ 3.95万 - 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
- 批准号:
10622209 - 财政年份:2023
- 资助金额:
$ 3.95万 - 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
- 批准号:
22H03963 - 财政年份:2022
- 资助金额:
$ 3.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
- 批准号:
10537709 - 财政年份:2022
- 资助金额:
$ 3.95万 - 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
- 批准号:
10388929 - 财政年份:2022
- 资助金额:
$ 3.95万 - 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
- 批准号:
10356565 - 财政年份:2022
- 资助金额:
$ 3.95万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10708827 - 财政年份:2022
- 资助金额:
$ 3.95万 - 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
- 批准号:
10538071 - 财政年份:2022
- 资助金额:
$ 3.95万 - 项目类别: